Related Experiment Video
Updated: Oct 29, 2025
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
26.1K
Type 2 Diabetes Medication and Cardiovascular Benefits
Anup Shrestha1,2, Raiko Munankarmi2
1Department of Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Summary
Diabetes management is crucial for preventing cardiovascular complications. Newer medications like SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 analogues show promise in improving cardiac outcomes, similar to insulin and metformin.
Area of Science:
- Endocrinology
- Cardiology
- Pharmacology
Background:
- Diabetes mellitus is a global health concern with high rates of cardiovascular complications.
- While glycemic control prevents microvascular issues, its impact on macrovascular disease (cardiovascular disease) is unproven.
- Certain diabetes medications (dual PPAR-agonists, sulfonylureas) can exacerbate cardiovascular conditions.
Purpose of the Study:
- To review the cardiovascular effects of various diabetes medications.
- To identify diabetes treatments that do not worsen cardiac outcomes.
Main Methods:
- Literature review of studies on diabetes medications and cardiovascular outcomes.
- Analysis of clinical trial data and observational studies.
Main Results:
- Insulin and Metformin are established treatments for preventing cardiac worsening.
- Newer drug classes, including SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 analogues, demonstrate comparable efficacy in improving cardiovascular outcomes.
- Dual PPAR-agonists and sulfonylureas are associated with increased heart failure readmissions and cardiovascular death.
Conclusions:
- Newer diabetes medications (SGLT2 inhibitors, DPP-4 inhibitors, GLP-1 analogues) offer safe and effective alternatives for managing diabetes, particularly in patients with cardiovascular concerns.
- Clinicians should carefully consider medication choices to avoid adverse cardiac events in diabetic patients.
More Related Videos
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
368
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
368
01:22Diabetes Mellitus: Type 2 and Gestational
3.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
01:15Diabetes: Management and Pharmacotherapy
618
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
618
01:36Carbohydrate Metabolism
12.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.7K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
01:26Atherosclerosis III: Management
84
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
84